20 minutos – Marañón Explores Thymus Cells as a Key to Combating Crohn’s Disease and Transplant Rejection
Preventing rejection after transplantation and improving the treatment of diseases such as Crohn’s disease or diabetes. Hospital General Universitario Gregorio Marañón is investigating a new therapy based on the use of cells extracted from discarded pediatric tissues that makes it possible to regulate the body’s immune response and prevent it from attacking itself. This pioneering […]
El Confidencial digital – Guinda Recognizes Hospital Gregorio Marañón for Its Advances in Pediatric Heart Transplantation
Guinda recognizes the researchers of the Immunoregulation Laboratory at Hospital General Universitario Gregorio Marañón for developing a treatment based on a cellular therapy designed to prevent immune rejection and potentially extend the survival of transplanted organs indefinitely, thereby prolonging patients’ lives. This therapy has already been administered to seven infants who underwent heart transplantation, in […]
El País – The Good News Hidden in Irene’s Heart
Three years after the transplant and the application of a pioneering technique, some of the child’s immunological markers remain stable, opening the door to longer graft survival with reduced immunosuppressive therapy. More info: elpais.com
Gaceta Médica – Hospital Gregorio Marañón Develops a Therapy Demonstrating Safety and Efficacy in Preventing Rejection in Pediatric Heart Transplantation
Researchers from the Immunoregulation Laboratory at Hospital General Universitario Gregorio Marañón have developed a treatment unique worldwide based on a cellular therapy using thyTreg cells to prevent immune rejection and potentially extend the survival of the transplanted organ indefinitely, thereby prolonging the patient’s life. To date, seven infants who underwent heart transplantation have been successfully […]
Salud a diario – Safe and Effective Therapy to Prevent Rejection in Pediatric Heart Transplantation
For the first time, cells obtained from thymic tissue have been used to regulate immune system responses and prevent transplant rejection. Seven infants who underwent heart transplantation have already been treated with this therapy. Researchers from the Immunoregulation Laboratory at Hospital General Universitario Gregorio Marañón, a public hospital in the Community of Madrid, have developed […]
Comunidad de Madrid – The treatment developed at Hospital Gregorio Marañón to prevent rejection in pediatric heart transplantation demonstrates safety and efficacy.
A Therapy Based on Thymic-Derived thyTreg Cells Researchers from the Immunoregulation Laboratory at Hospital General Universitario Gregorio Marañón, a public hospital in the Community of Madrid, have developed a treatment that is unique worldwide. The therapy is based on a cellular approach using thymic-derived thyTreg cells to prevent immune rejection and potentially extend the survival […]
Fuentes informadas – A Therapy from Gregorio Marañón Enables Seven Heart-Transplanted Infants to Show No Signs of Rejection
Preliminary results suggest that a single administration of this treatment is capable of restoring immune balance. Researchers from the Immunoregulation Laboratory at Hospital General Universitario Gregorio Marañón have successfully treated seven infants who underwent heart transplantation with a treatment unique worldwide. The therapy is based on a cellular approach using thyTreg cells to prevent immune […]
infobae – Seven Infant Heart Transplant Patients Show No Rejection Thanks to a Therapy Developed at Gregorio Marañón
Researchers from the Immunoregulation Laboratory at Hospital General Universitario Gregorio Marañón have successfully treated seven infants who underwent heart transplantation with a treatment unique worldwide. The therapy is based on a cellular approach using thyTreg cells to prevent immune rejection and potentially extend the survival of the transplanted organ indefinitely, thereby prolonging the patient’s life. […]
El Español – The Spanish Biotech Company Aiming to Cure Autoimmune Diseases
Thytech has successfully developed a pioneering cell therapy to prevent rejection in infant heart transplant recipients. The startup is now seeking to expand its applications to treat autoimmune diseases in adults. Congenital heart defects affect one in every 100 newborns. They are the most common birth-related conditions in Spain, with around 4,000 new cases each […]
Europapress – Banco Sabadell Leads the €350,000 First Investment Round of Medtech Company Thytech
Banco Sabadell has led the first investment round of medtech company Thytech, which closed at €350,000. This marks the second investment under the fourth edition of the BStartup Health program, which received applications from 121 startups. Thytech was founded by researchers from the Health Research Institute of Hospital General Universitario Gregorio Marañón (IISGM) in Madrid […]
